MARC Record from marc_columbia

LEADER: 02229cam a2200457 a 4500
001 3931598
005 20221027003030.0
008 871201t19871987nyua b 101 0 eng d
010 $a 87020260
020 $a0306425882
035 $a(OCoLC)16227183
035 $a(OCoLC)ocm16227183
035 $a(CStRLIN)NYCM87-B4435
035 $9ADJ4415HS
035 $a(NNC)3931598
035 $a3931598
040 $aDNLM/DLC$cDLC
050 00 $aRC694.3$b.I575 1986
060 0 $aQV 193 I613n 1986
082 0 $a616.1/35061$219
111 2 $aInternational Symposium on the New Dimensions of Warfarin Prophylaxis$d(1986 :$cNew York University Medical Center)$0http://id.loc.gov/authorities/names/n87846916
245 14 $aThe new dimensions of warfarin prophylaxis /$cedited by Stanford Wessler, Carl G. Becker, and Yale Nemerson.
260 $aNew York :$bPlenum Press,$c[1987], ©1987.
300 $aix, 329 pages :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAdvances in experimental medicine and biology ;$vv. 214
500 $a"Proceedings of the International Symposium on the New Dimensions of Warfarin Prophylaxis, held October 16-18, 1986, at the New York University Medical Center in New York"--T.p. verso.
504 $aIncludes bibliographies and index.
650 0 $aWarfarin$xTherapeutic use$vCongresses.
650 0 $aThrombolytic therapy$vCongresses.
650 0 $aThrombosis$xPrevention$vCongresses.
650 2 $aThromboembolism$xprevention & control.$0https://id.nlm.nih.gov/mesh/D013923Q000517
650 2 $aWarfarin$xpharmacology.$0https://id.nlm.nih.gov/mesh/D014859Q000494
650 2 $aWarfarin$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D014859Q000627
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aWessler, Stanford,$d1917-2005.$0http://id.loc.gov/authorities/names/n87894859
700 1 $aBecker, Carl G.$0http://id.loc.gov/authorities/names/n87894860
700 1 $aNemerson, Yale.$0http://id.loc.gov/authorities/names/n87894858
830 0 $aAdvances in experimental medicine and biology ;$vv. 214.$0http://id.loc.gov/authorities/names/n42001229
852 00 $boff,hsl$hRC694.3$i.I575 1986